Novartis flu vax late to the party

Most of Novartis' swine flu vaccine may not reach the U.S. until the first quarter of 2010, almost at the end of flu season, CEO Daniel Vasella said. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.